Awards & Advancement

Regenesis Biomedical names Scott Brooks as CEO

Friday, May 17, 2013 11:28 AM

The board of directors of Regenesis Biomedical, a privately held medical technology company focused on tissue regeneration, has unanimously elected Scott Brooks as the next chief executive officer and member of the board of directors, succeeding Virginia Rybski. Brooks will assume his new role immediately.

More... »

Chiltern appoints Niewel and Bull to senior positions

Thursday, May 16, 2013 08:00 AM

Chiltern International, a global CRO based in the U.K., has appointed Dr. Manuela Niewel as medical director and Lisa Bull as director of strategic partnerships.

More... »

Third Rock Ventures expands, strengthens team

Wednesday, May 15, 2013 09:38 AM

Third Rock Ventures, a venture capital firm focused on building healthcare companies, has expanded and strengthened its team with several appointments and role changes. These additions allow Third Rock to continue to support the launch of new companies focused on disruptive areas of science and medicine, the maturation and development of its current portfolio companies and the overall strategy and direction of the firm.

More... »

Wierman appointed Theorem vice president of biopharmaceutical development

Monday, May 13, 2013 08:00 AM

Theorem Clinical Research, a King of Prussia, Penn.-based, mid-sized provider of comprehensive clinical research and development services, has appointed Connie Wierman as vice president of biopharmaceutical development. Wierman leads the company’s oncology therapeutic focus for the biopharmaceutical business unit.

More... »

Former FDA official Tim Cote joins Emmaus Medical as regulatory advisor

Friday, May 10, 2013 08:00 AM

Emmaus Medical, a specialty pharmaceutical and regenerative medicine company, has appointed Timothy Cote, M.D., MPH, former director of the Office of Orphan Product Development of the FDA, as its regulatory advisor. Cote will advise Emmaus on the regulatory pathway for the company's sickle cell disease treatment.

More... »

JDRF appoints David E. Wheadon as executive vice president of research and advocacy

Thursday, May 9, 2013 12:04 PM

Juvenile Diabetes Research Foundation (JDRF), a global organization funding type 1 diabetes (T1D) research, has appointed David E. Wheadon, M.D., as its new executive vice president of research and advocacy.

More... »

Sanofi appoints two new members to executive committee

Friday, May 3, 2013 12:22 PM

Global healthcare company Sanofi is creating two new units, global commercial operations and global divisions and strategic commercial development, to replace the former global operations unit. Peter Guenter, currently senior vice president, Europe, will be appointed executive vice president of global commercial operations. Pascale Witz, currently president and CEO of medical diagnostics at GE Healthcare, will join Sanofi as executive vice president of global divisions and strategic commercial development. Both Guenter and Witz will join the executive committee.

More... »

BioDelivery Sciences appoints Thomas W. D'Alonzo to board of directors

Tuesday, April 30, 2013 08:00 AM

BioDelivery Sciences International, a specialty pharmaceutical company, has appointed Thomas W. D'Alonzo to the company's board of directors.

More... »

PAREXEL honored with 2013 "Partnership Pioneers of the Year" Award

Monday, April 29, 2013 11:09 AM

PAREXEL International, a global biopharmaceutical services provider, has been named a recipient of the 2013 "Partnership Pioneers of the Year" award in recognition of its innovative strategic partnership with Pfizer and ICON.

More... »

David A. Dodd appointed president and CEO of Aeterna Zentaris

Friday, April 26, 2013 03:05 PM

Aeterna Zentaris, an oncology and endocrinology drug development company, has appointed David A. Dodd as president and CEO, succeeding Juergen Engel, PhD. Dodd has also been appointed director on the company's board of directors.

More... »